| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.061 | 0.3 |